The presentation, “Preventing Relapse in MH&A Recovery: How Axon Health is Reinventing Aftercare via Remote Monitoring” addresses a persistent yet under-served challenge in mental health: the lack of effective, scalable aftercare to prevent relapse post-treatment. Globally, up to 85% of individuals with substance use disorders relapse within the first year following treatment based on a NIH study. Despite significant investment in primary treatment programs, aftercare services remain fragmented, non-personalized, and reactive. Many clinics struggle to stay engaged with clients post-discharge, leading to poorer outcomes, increased costs, and preventable readmissions. For populations in rural or underserved areas, access to structured aftercare is even more limited. Axon Health introduces a Remote Therapy Monitoring (RTM) platform which is designed specifically for outpatient and residential mental health and addiction recovery settings with the aim to bridge this aftercare gap. While digital mental health tools have proliferated, few are tailored for the critical post-treatment phase. This presentation introduces a novel framework where real-time patient engagement, daily self-monitoring, and outcome-driven insights are integrated into a seamless aftercare experience. Residential rehabs using Axon Health gain: 1. An automated, structured, and personalized approach to continuing care 2. Data-driven insights that enable early intervention before relapse occurs 3. Enhanced therapist-client communication via secure digital channels 4. A scalable solution that improves outcomes while reducing clinician burnout Presentation Structure 1. Introduction to the Problem a. Global relapse rates in mental health and addiction recovery b. The cost of poor aftercare: human, social, and financial c. Gaps in existing aftercare approaches 2. The Innovation: Axon Health RTM Platform a. Core features: EMAs, symptom tracking, secure document sharing, alerts b. Personalization and adaptive goal-setting c. Therapist dashboard and analytics capabilities d. Real-world use case: “Sarah’s Journey” through recovery 3. Evidence and Outcomes a. Pilot feedback from clinics and users b. Indicators of improved engagement and self-efficacy c. Alignment with key metrics: reduced dropout, increased accountability 4. Equity and Global Relevance a. Accessibility: RTM as a tool to reach rural, remote, and marginalized populations b. Affordability and scalability across systems c. Cultural adaptability and clinical integration 5. Conclusion & Call to Action a. The urgency of investing in aftercare innovation b. Policy recommendations and future research directions c. Invitation for collaboration and clinical pilots My talk offers attendees a scalable, evidence-informed model to close the aftercare gap using RTM; a solution that is timely, cost-effective, and globally relevant. It reflects the Congress’s 2025 theme, “Global Mental Health Equity,” by addressing one of the most pressing post-treatment challenges with a practical, technology-enabled approach that can adapt across cultures and health systems.